MedPath

Exercise Rehabilitation for Children With Asthma

Not Applicable
Not yet recruiting
Conditions
Asthma in Children
Rehabilitation
Exercise
Interventions
Behavioral: Personalized Exercise Rehabilitation
Registration Number
NCT06272604
Lead Sponsor
The Children's Hospital of Zhejiang University School of Medicine
Brief Summary

Asthma, a prevalent chronic condition among children and adolescents, substantially impairs their quality of life. In addressing this significant health concern, this study focuses on the potential of a customized exercise rehabilitation program tailored for this young demographic. By employing a randomized controlled trial design, the research aims to divide participants into two distinct groups: one undergoing a personalized exercise regimen and the other receiving standard medical care. The 12-week intervention for the exercise group includes a combination of aerobic activities, strength training, and targeted breathing exercises. The study's primary aim is to rigorously evaluate the impact of this specialized exercise protocol on critical health aspects such as lung function, physical endurance, frequency of asthma attacks, and overall quality of life. The anticipated findings from this research are expected to shed new light on effective asthma management strategies and offer invaluable guidance for clinical practices dedicated to improving health outcomes in young asthma patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Diagnosed with bronchial asthma;
  2. No acute asthma attacks in the past three months;
  3. Currently undergoing stable prophylactic treatment for asthma, with no changes in the treatment plan in the past three months.
Exclusion Criteria
  1. Suffering from other severe heart, lung, or musculoskeletal diseases;
  2. Frequent acute asthma attacks or recent hospitalization records;
  3. Changes in asthma medication treatment plan in the last three months;
  4. Currently participating in other clinical trials that could affect the results of this study;
  5. Any medical contraindications, such as severe exercise-induced asthma or other health issues affecting the ability to exercise;
  6. Severe psychological or behavioral issues that may affect participation in training or adherence to the research protocol.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Exercise Rehabilitation GroupPersonalized Exercise RehabilitationThe experimental group will participate in a 12-week exercise intervention program.
Primary Outcome Measures
NameTimeMethod
Daily Physical Activity Levelup to 24 weeks

Daily Step Count (as measured by a pedometer), Energy Expenditure,Time Spent in Moderate-to-Vigorous Intensity Activity

Lung Functionup to 24 weeks

Forced Vital Capacity (FVC), Forced Expiratory Volume in One Second (FEV1), Forced Expiratory Flow 25% to 75% (FEF25-75), Peak Expiratory Flow (PEF)

Secondary Outcome Measures
NameTimeMethod
Asthma Control Statusup to 24 weeks

asthma control test(ACT)

Fractional Exhaled Nitric Oxide (FeNO)up to 12 weeks

FeNO was determined by NIOX VERO

Anxiety and Depressionup to 24 weeks

C-C-Ped-PROMIS

Body Compositionup to 24 weeks

Height, Weight, Body Fat, Skeletal Muscle Content

Sleepup to 24 weeks

Number of Nighttime Awakenings, Sleep Duration

Health Related Quality of Lifeup to 24 weeks

Asthma Quality of Life Questionnaire

Inflammatory Mediatorsup to 12 weeks

IL-4, IL-5, IL-13

© Copyright 2025. All Rights Reserved by MedPath